Question to the Department of Health and Social Care:

To ask His Majesty's Government what steps they are taking to find solutions for diabetes type one sufferers.

Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)

The goal of treating type 1 diabetes is to keep blood glucose within a healthy range by providing the body with supplemental insulin. The National Health Service, with the Department’s support, has taken a number of steps to help manage type 1 diabetes.

In line with the commitments in the NHS Long Term Plan, NHS England is driving access to new and existing technologies such as continual glucose monitors. This reflects the essential role that technology plays in allowing individuals with type 1 diabetes to manage their blood sugars correctly and avoid dangerous complications. Furthermore, maternity services across the country are now offering continuous glucose monitors to expectant mothers with type 1 diabetes.

Finally, approximately 72% of children and young people living with type 1 diabetes have registered with the Digibete app, which helps users manage their type 1 diabetes. Over 250,000 unique users have accessed the open access adult website, with over 3,800 education modules undertaken.

Question to the Department of Health and Social Care:

To ask His Majesty's Government what incentives they are offering to medical partnerships to assist type two diabetes sufferers through research into both stem-cell and non-stem-cell treatments for diabetes type one sufferers.

Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)

The Department is delivering improvements as part of the Vision for the Future of UK Clinical Research Delivery to make the United Kingdom a world leader in clinical research, attracting investment from commercial companies to deliver cutting edge research in a range of disease areas, including diabetes. For example, we introduced the National Contract Value Review to standardise costing and contracting for commercial research in the National Health Service.

This has reduced set up times for clinical research by a third which makes running research in the UK more efficient for commercial companies.

The National Institute for Health and Care Research’s (NIHR) Clinical Research Network (CRN) supports conduct of clinical research in the NHS, providing tailored support for both non-commercial organisations and the life sciences industry. The CRN has a Diabetes Speciality Group to support research across key priorities in diabetes.

The NIHR works in partnership with Diabetes UK to deliver the joint UK Strategy for Clinical and Applied Diabetes Research. The NIHR also funds a Global Health Research Unit on Diabetes and Cardiovascular Disease in South Asia, creating partnerships between research organisations in Bangladesh, India, Pakistan, Sri Lanka and the UK.

Question to the Department of Health and Social Care:

To ask His Majesty's Government what incentives they are offering to commercial operators to form medical partnerships to advance stem-cell and non-stem-cell treatments for diabetes type one sufferers.

Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)

The Department is delivering improvements as part of the Vision for the Future of UK Clinical Research Delivery to make the United Kingdom a world leader in clinical research, attracting investment from commercial companies to deliver cutting edge research in a range of disease areas, including diabetes. For example, we introduced the National Contract Value Review to standardise costing and contracting for commercial research in the National Health Service.

This has reduced set up times for clinical research by a third which makes running research in the UK more efficient for commercial companies.

The National Institute for Health and Care Research’s (NIHR) Clinical Research Network (CRN) supports conduct of clinical research in the NHS, providing tailored support for both non-commercial organisations and the life sciences industry. The CRN has a Diabetes Speciality Group to support research across key priorities in diabetes.

The NIHR works in partnership with Diabetes UK to deliver the joint UK Strategy for Clinical and Applied Diabetes Research. The NIHR also funds a Global Health Research Unit on Diabetes and Cardiovascular Disease in South Asia, creating partnerships between research organisations in Bangladesh, India, Pakistan, Sri Lanka and the UK.

Question to the Department of Health and Social Care:

To ask His Majesty's Government what steps they are taking to promote international cooperation and joint research to find solutions for both type one and type two diabetes sufferers.

Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)

The Department is delivering improvements as part of the Vision for the Future of UK Clinical Research Delivery to make the United Kingdom a world leader in clinical research, attracting investment from commercial companies to deliver cutting edge research in a range of disease areas, including diabetes. For example, we introduced the National Contract Value Review to standardise costing and contracting for commercial research in the National Health Service.

This has reduced set up times for clinical research by a third which makes running research in the UK more efficient for commercial companies.

The National Institute for Health and Care Research’s (NIHR) Clinical Research Network (CRN) supports conduct of clinical research in the NHS, providing tailored support for both non-commercial organisations and the life sciences industry. The CRN has a Diabetes Speciality Group to support research across key priorities in diabetes.

The NIHR works in partnership with Diabetes UK to deliver the joint UK Strategy for Clinical and Applied Diabetes Research. The NIHR also funds a Global Health Research Unit on Diabetes and Cardiovascular Disease in South Asia, creating partnerships between research organisations in Bangladesh, India, Pakistan, Sri Lanka and the UK.

Question to the Department of Health and Social Care:

To ask His Majesty's Government what partnerships and expedients they are encouraging to progress diabetes type one stem cell and non-stem-cell research.

Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)

The Department is delivering improvements as part of the Vision for the Future of UK Clinical Research Delivery to make the United Kingdom a world leader in clinical research, attracting investment from commercial companies to deliver cutting edge research in a range of disease areas, including diabetes. For example, we introduced the National Contract Value Review to standardise costing and contracting for commercial research in the National Health Service.

This has reduced set up times for clinical research by a third which makes running research in the UK more efficient for commercial companies.

The National Institute for Health and Care Research’s (NIHR) Clinical Research Network (CRN) supports conduct of clinical research in the NHS, providing tailored support for both non-commercial organisations and the life sciences industry. The CRN has a Diabetes Speciality Group to support research across key priorities in diabetes.

The NIHR works in partnership with Diabetes UK to deliver the joint UK Strategy for Clinical and Applied Diabetes Research. The NIHR also funds a Global Health Research Unit on Diabetes and Cardiovascular Disease in South Asia, creating partnerships between research organisations in Bangladesh, India, Pakistan, Sri Lanka and the UK.